David Warren awarded by American Association of Clinical Chemistry
AACC is known for the journal Clinical Chemistry, the most cited in the field (impact factor 7.717), and for the annual AACC meeting, the world's largest lab conference with about 17,000-19,000 registrants from more than 100 countries.
Warren's winning article, entitled Useof an In Vivo Biotinylated Single-Chain Antibody as Capture Reagent in an Immunometric Assay to Decrease the Incidence of Interference from Heterophilic Antibodies, describes an elegant new approach to eliminate common inferences in immunometric methods, which if successfully implemented could produce more accurate results in these widely used tests. The papers co-authors were Johan Bjerner, Elisabeth Paus, Ole P. Børmer, and Kjell Nustad, also from the Central Laboratory at the RR HF Montebello.
AACC's Hall of Fame recognizes those individuals who have made significant and unique contributions to fleld and to the association. As a winner of a major award from AACC, David Warren is included here.
Links:
Link to summary of the winning article from PubMed:
Warren DJ, Bjerner J, Paus E, Bormer OP, Nustad K. Use of an In Vivo Biotinylated Single-Chain Antibody as Capture Reagent in an Immunometric Assay to Decrease the Incidence of Interference from Heterophilic Antibodies Clin Chem. 2005 May;51(5):830-8.
The Sigi Ziering Award for Outstanding Contribution for a Publication in the Journal Clinical Chemistry - David J. Warren, PhD - 2006
About the Sigi Ziering Award for Outstanding Contribution for a Publication in the Journal Clinical Chemistry
About ACC awards
The Central Laboratory at RR HF Montebello